Biopharmas raising money in public or private financings, including: Adamis, Arcutis, Argenx, Bexson, Biondvax, Biophytis, Coya, Cytomx, Evgen, Hemogenyx, Janone, Krystal, Medexus, Moleculin, Mybiotics, NLS, Outlook, Reverie, Sana.

Quarterly snapshots from biopharma companies with marketed products, including: Amgen, Biogen.

New hires and promotions in the biopharma industry, including: Indapta, Jnana, Kymera, M6P, Tryp.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Amgen, Antengene, Ascentage, Astrazeneca, Biogen, Biontech, Bio-Thera Solutions, Edesa, Eisai, Faron, Gan & Lee, Harbour, HBM, Immunoforge, JCR, Jeil, Kintor, Opko Health, Pfizer, Rockwell Medical, Russian Direct Investment Fund, Shanghai Fosun.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Appili, Astrazeneca, Beigene, Daiichi Sankyo, Dimerix, Dr. Reddy’s, Dynavax, Eli Lilly, Eucure Beijing, Glaxosmithkline, Humanigen, I-Mab, Immutep, Innovation, Johnson & Johnson, Lead Discovery Center, Morphosys, Novavax, Oncosec Medical, Qurient, Redhill, Regeneron, Sichuan Clover, Sorrento, Takeda, Valneva, VBL, Vicore, Vir.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Chimeric.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Affyxell, Avacta, Curevac, Daewoong, Onxeo, Tevogen.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Adagio, Adamis, Ajinomoto Bio-Pharma Services, Allarity, Asahi Kasei, Aslan, Astellas, Biontech, Citrine Medicine, Cosmo, Curevac, Diurnal, Eli Lilly, Evotec, Humanetics, Humanigen, I-Mab, JCR, Just-Evotec Biologics, Lumen, Medolife Rx, Metrion, Moderna, Morphosys, Noveome, Nyrada, Pfizer, Recordati, Redhill, Rentschler, Rigel, Shanghai Jiao Tong University, Sosei, Sumitomo Dainippon, Tolmar International, Valneva, Vaxart, Vaxil, Vir.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CDC reports on cases, sequencing; NICE says savings seen with Cytosorb; IP at issue as WTO pushes for global pandemic effort; Researcher gets prison time for trade secret theft; USPTO responds to COVID-19 challenge.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inovytec, Johnson & Johnson Vision.